US-based software company DigiSight Technologies has secured $7.8m in a series B round featuring GE Ventures, the corporate venturing unit of conglomerate General Electric.
Biosys Capital, Waycross Ventures and Lagunita also participated in the round, alongside undisclosed existing investors. The company has not disclosed previous rounds.
DigiSight’s technology enables remote, real-time patient monitoring by sending data of obtained through patients’ mobile devices to doctors using a secure connection. It is currently focusing on commercialising technology for ophthalmology.
DigiSight, a spin-out of Stanford University that was founded by Mark Blumenkranz and Daniel Palanker, will use the series B funding to develop its software for remote monitoring in other clinical areas.